Small animal models in which in vivo HIV-1 infection, pathogenesis, and immune responses can be studied would permit both basic research on the biology of the disease, as well as a system to rapidly screen developmental therapeutics and/or vaccines. To date, the most widely-used models have been the severe combined immunodeficient (SCID)-hu (also known as the thy/liv SCID-hu) and the huPBLSCID mouse models. Recently three new models have emerged, i.e., the intrasplenic huPBL/SPL-SCID model, the NOD/SCID/IL2Rγnull mouse model, and the Rag2−/−γ−/ c − mouse model. Details on the construction, maintenance and HIV-1 infection of these models are discussed.
CITATION STYLE
Aiken, C. (2000). HIV Protocols. Journal of Antimicrobial Chemotherapy, 46(1), 155–155. https://doi.org/10.1093/jac/46.1.155
Mendeley helps you to discover research relevant for your work.